Viewray (VRAY) Issues Quarterly Earnings Results, Beats Estimates By $0.06 EPS

Share on StockTwits

Viewray (NASDAQ:VRAY) issued its quarterly earnings results on Thursday. The company reported ($0.17) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.23) by $0.06, Briefing.com reports. The business had revenue of $20.66 million for the quarter, compared to the consensus estimate of $20.38 million. Viewray had a negative net margin of 105.09% and a negative return on equity of 105.63%. The firm’s quarterly revenue was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.38) EPS. Viewray updated its FY 2019 guidance to EPS.

NASDAQ:VRAY traded down $0.19 on Friday, hitting $8.15. 1,355,132 shares of the stock were exchanged, compared to its average volume of 1,252,275. The stock has a market capitalization of $798.39 million, a P/E ratio of -7.84 and a beta of 1.30. Viewray has a 52 week low of $4.86 and a 52 week high of $13.21. The company has a current ratio of 6.47, a quick ratio of 5.56 and a debt-to-equity ratio of 0.25.

A number of large investors have recently made changes to their positions in VRAY. Bank of America Corp DE raised its holdings in Viewray by 209.7% during the 2nd quarter. Bank of America Corp DE now owns 14,710 shares of the company’s stock worth $101,000 after purchasing an additional 9,960 shares during the last quarter. Northern Trust Corp increased its stake in shares of Viewray by 61.1% in the 2nd quarter. Northern Trust Corp now owns 545,384 shares of the company’s stock valued at $3,775,000 after acquiring an additional 206,783 shares during the last quarter. Russell Investments Group Ltd. increased its stake in shares of Viewray by 46.7% in the 3rd quarter. Russell Investments Group Ltd. now owns 605,262 shares of the company’s stock valued at $5,671,000 after acquiring an additional 192,637 shares during the last quarter. Wells Fargo & Company MN increased its stake in shares of Viewray by 46.0% in the 3rd quarter. Wells Fargo & Company MN now owns 141,048 shares of the company’s stock valued at $1,320,000 after acquiring an additional 44,415 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of Viewray by 5,511.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 564,294 shares of the company’s stock valued at $5,282,000 after acquiring an additional 554,237 shares during the last quarter.

Several research analysts recently issued reports on VRAY shares. Cantor Fitzgerald reiterated a “buy” rating and set a $13.00 price target on shares of Viewray in a research report on Thursday, December 6th. Northland Securities reiterated a “buy” rating and set a $20.00 price target on shares of Viewray in a research report on Thursday, December 6th. Morgan Stanley started coverage on shares of Viewray in a research report on Tuesday, December 11th. They set an “equal weight” rating and a $7.00 price target on the stock. BidaskClub downgraded shares of Viewray from a “hold” rating to a “sell” rating in a research report on Tuesday, December 25th. Finally, Guggenheim began coverage on Viewray in a report on Tuesday, January 15th. They set a “buy” rating and a $13.00 price objective for the company. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and an average price target of $12.63.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another site, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright legislation. The legal version of this news story can be accessed at https://www.tickerreport.com/banking-finance/4223606/viewray-vray-issues-quarterly-earnings-results-beats-estimates-by-0-06-eps.html.

Viewray Company Profile

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Featured Article: How to Track your Portfolio in Google Finance

Earnings History for Viewray (NASDAQ:VRAY)

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Purex  Price Up 15.7% This Week
Purex Price Up 15.7% This Week
T-Mobile Us Inc  Receives Average Rating of “Buy” from Brokerages
T-Mobile Us Inc Receives Average Rating of “Buy” from Brokerages
First Interstate Bancsystem Inc  CEO Sells $196,800.00 in Stock
First Interstate Bancsystem Inc CEO Sells $196,800.00 in Stock
Laredo Petroleum  Shares Gap Down to $2.96
Laredo Petroleum Shares Gap Down to $2.96
Niobium Coin Hits 24 Hour Trading Volume of $6,348.00
Niobium Coin Hits 24 Hour Trading Volume of $6,348.00
Zacks: Greenlane Holdings  Receives Consensus Rating of “Strong Buy” from Analysts
Zacks: Greenlane Holdings Receives Consensus Rating of “Strong Buy” from Analysts


© 2006-2019 Ticker Report